-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DsUff+nsMjqSpuXIxEch4MIlMxHuychQfZcmT4JCGyhj+ZFGCp4+FDozdvnPGIJ3
 Nryr6GvuuBhsKZrEhh1Qcw==

<SEC-DOCUMENT>0000950136-02-001419.txt : 20020513
<SEC-HEADER>0000950136-02-001419.hdr.sgml : 20020513
ACCESSION NUMBER:		0000950136-02-001419
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20020513

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLARUS CORP
		CENTRAL INDEX KEY:			0000913277
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				581972600
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24277
		FILM NUMBER:		02642607

	BUSINESS ADDRESS:	
		STREET 1:		3970 JOHNS CREEK CT
		STREET 2:		STE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024
		BUSINESS PHONE:		7702913900

	MAIL ADDRESS:	
		STREET 1:		3970 JOHNS CREEK CT
		STREET 2:		STE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SQL FINANCIALS INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19980911

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KANDERS WARREN B
		CENTRAL INDEX KEY:			0000935577
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		C/O THE LANGER BIOMEDICS GROUP INC
		STREET 2:		450 COMMACK RD
		CITY:			DEER PARK
		STATE:			NY
		ZIP:			11729
		BUSINESS PHONE:		2035529600

	MAIL ADDRESS:	
		STREET 1:		C/O THE LANGER BIOMEDICS GROUP INC
		STREET 2:		450 COMMACK RD
		CITY:			DEER PARK
		STATE:			NY
		ZIP:			11729
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>file001.txt
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<PAGE>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 14A

                PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                                (AMENDMENT NO. )

Filed by the Registrant  [ ]     Filed by a Party other than the Registrant [X]

Check the appropriate box:

[ ]     Preliminary Proxy Statement

[ ]     Confidential, For Use of the Commission Only (as permitted by
        Rule 14a-6(e)(2))

[ ]     Definitive Proxy Statement

[X]     Definitive Additional Materials

[ ]     Soliciting Material Pursuant to Rule 14a-12

                               CLARUS CORPORATION
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                                WARREN B. KANDERS
                                BURTT R. EHRLICH
                                NICHOLAS SOKOLOW
    (NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)

Payment of filing fee (Check the appropriate box):

[X]      No fee required.

[ ]      Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
         and 0-11.

     (1) Title of each class of securities to which transaction applies:

     (2) Aggregate number of securities to which transaction applies:

     (3) Per unit price or other underlying value of transaction computed
         pursuant to





<PAGE>





         Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
         calculated and state how it was determined):

     (4) Proposed maximum aggregate value of transaction:

     (5) Total fee paid:

[ ]      Fee paid previously with preliminary materials.

[ ]      Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.

     (1) Amount previously paid:

     (2) Form, Schedule or Registration Statement No.:

     (3) Filing Party:

     (4) Date Filed:
















<PAGE>



                                WARREN B. KANDERS
                          c/o Kanders and Company, Inc.
                               Two Soundview Drive
                          Greenwich, Connecticut 06830



                                  May 10, 2002



VIA FACSIMILE TO 301-556-0491
Institutional Shareholder Services
2099 Gaither Road
Rockville, Maryland 20850
Attn:  Messrs. Ram Kumar and Ted Seaton

     Re:  Clarus Corporation/Nominations of Warren B. Kanders, Burtt R. Ehrlich
          and Nicholas Sokolow ("Kanders Nominees") to Board of Directors

Dear Sirs:

     We are writing to you in connection with the pending proxy contest for the
election of three directors to Clarus Corporation's Board of Directors. We
believe that the Kanders Nominees are the clear choice to guide Clarus toward
profitability and increased stockholder value. In support of this view, set
forth below are certain guiding principles that we believe are of utmost
importance in this proxy contest, and the respective positions of the Kanders
Nominees and management's nominees:

<TABLE>
<CAPTION>
Issues:                                  Kanders Nominees                       Management's Nominees
- -------                                  ----------------                       ---------------------
<S>                                      <C>                                    <C>
Staggered Board of Directors:            Opposed to a staggered Board, and in   For a staggered Board consisting of
                                         favor of all directors being elected   three classes of directors.
                                         every year.

Board Nominating Committee:              Favors a Nominating Committee          Did not have a Nominating Committee
                                         without any management                 until this proxy season and a member
                                         representation on such committee.      of the committee has a consulting
                                                                                arrangement with Clarus.

Transactions with Clarus:                None.                                  Two directors have consulting and
                                                                                other arrangements with Clarus.

<PAGE>

Stock Ownership by Directors:            Favors Directors owning stock as it    All management nominees collectively
                                         aligns directors' interests with       own less than 0.3%.
                                         those of stockholders. Kanders
                                         Nominees have an approximately 5.6%
                                         interest in Clarus.

Management Success:                      Multifold increases in investments.    Have presided over Clarus while:
                                         Armor Holdings - initial investment    over $1.7 Billion in market
                                         at $0.76 per share in January 1996,    capitalization has been lost; over
                                         current value $25.25 per share on      $190 million in losses have been
                                         May 9, 2002; Benson Eycare - initial   incurred over two years; 50%
                                         investment at $0.375 per share in      reduction in revenues during 2001
                                         January 1992, increased to $10.25      compared with 2000; $36.8 million in
                                         per share in summer 1995 when          writeoffs of purchased assets; and
                                         investment was sold; Langer, Inc. -    repricing of options for employees.
                                         initial investment at $1.52 per
                                         share in February 2001, current
                                         value $8.25 per share on May 9, 2002.
</TABLE>

         In view of the foregoing, we trust that you will recommend the Kanders
Nominees to Clarus' stockholders at the upcoming annual meeting. If there are
any questions that you have regarding the above, I will be happy to answer them.
Thank you for your consideration.

                                                  Very truly yours,



                                                  Warren B. Kanders



</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
